《大行報告》華泰證券升新東方(EDU.US)目標價至102.45美元 業務多元化碩果纍纍
華泰證券升發表報告指,新東方(EDU.US)第二財季實現營收8.7億美元,超過此前7.85至8.04億美元的指引;non-GAAP經營利潤為0.51億美元,對應non-GAAP經營利潤率為5.9%,勝市場預期。第三財季收入指引為10.71億至10.93億美元,按年增長42%至45%。
該行指,考慮到線下培訓需求持續強勁,教學網絡穩步擴張,電商業務品牌運作持續深化,文旅業務加快全國佈局等因素,預計新東方2024至2026財季non-GAAP淨利潤分別為4.71億、6.91億及8.25億美元,目標價為102.45美元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.